Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
The batch-specific COA is included with every order, documenting purity 99% for both components
BENEFITS Combined mechanism studied for complementary tissue-repair pathways in a single formulation Convenience eliminates the need to source and reconstitute two separate vials Recovery research explored for combined effects on connective tissue and muscle models Anti-inflammatory linked to dual anti-inflammatory pathways from both compounds Wound healing associated with accelerated recovery timelines in preclinical models WHAT RESEARCHERS LOOK AT Synergistic vs additive effects of BPC-157 and TB-500 co-administration Angiogenesis promotion from the dual-peptide combination Comparative recovery timelines: blend vs individual compounds Optimal dosing ratios in combined formulations Fibroblast migration and collagen deposition from dual pathways QUICK SPECS Form: Lyophilized peptide blend Net per vial: 10 mg total (BPC-157 5mg + TB-500 5mg) Purity: 99% (HPLC verified) Identity: MS-verified (per COA) Storage: 28C, protect from light and moisture Reconstitution: Use bacteriostatic water (sold separately) IDENTITY BASICS Components: BPC-157 (CAS 137525-51-0) + TB-500 (CAS 77591-33-4) Blend ratio: 1:1 (5mg each) WHY CHOOSE DURHAM PEPTIDES FOR THE WOLVERINE STACK
What monitoring will you do
It demonstrates cytoprotective effects by enhancing eNOS activity through Src kinase-caveolin-1 signaling
This beyond-use date follows USP 797 pharmaceutical compounding standards for multi-dose vials
Transcure cuts denial rates by up to 4% through pre-submission scrubbing and Q-modifier QA
US$ 24.79
US$ 20.52
US$ 27.78
